585 related articles for article (PubMed ID: 15891271)
1. Management of myasthenia gravis.
Schwendimann RN; Burton E; Minagar A
Am J Ther; 2005; 12(3):262-8. PubMed ID: 15891271
[TBL] [Abstract][Full Text] [Related]
2. Myasthenia gravis: clinical features, pathogenesis, evaluation, and medical management.
Heitmiller RF
Semin Thorac Cardiovasc Surg; 1999 Jan; 11(1):41-6. PubMed ID: 9930711
[TBL] [Abstract][Full Text] [Related]
3. Essentials in the management of myasthenia gravis.
Galdi AP
Am Fam Physician; 1978 Jun; 17(6):95-102. PubMed ID: 655080
[TBL] [Abstract][Full Text] [Related]
4. Overview of myasthenia gravis.
Arora Y; Li Y
Hosp Pract (1995); 2013; 41(4):40-50. PubMed ID: 24145588
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic options in autoimmune myasthenia gravis.
García-Carrasco M; Escárcega RO; Fuentes-Alexandro S; Riebeling C; Cervera R
Autoimmun Rev; 2007 Jun; 6(6):373-8. PubMed ID: 17537383
[TBL] [Abstract][Full Text] [Related]
6. Clinical correlates with anti-MuSK antibodies in generalized seronegative myasthenia gravis.
Evoli A; Tonali PA; Padua L; Monaco ML; Scuderi F; Batocchi AP; Marino M; Bartoccioni E
Brain; 2003 Oct; 126(Pt 10):2304-11. PubMed ID: 12821509
[TBL] [Abstract][Full Text] [Related]
7. Management of myasthenia gravis.
Saperstein DS; Barohn RJ
Semin Neurol; 2004 Mar; 24(1):41-8. PubMed ID: 15229791
[TBL] [Abstract][Full Text] [Related]
8. Intravenous immune globulin in myasthenia gravis.
Gajdos P
Clin Exp Immunol; 1994 Jul; 97 Suppl 1(Suppl 1):49-51. PubMed ID: 8033435
[TBL] [Abstract][Full Text] [Related]
9. Myasthenia gravis.
Silvestri NJ; Wolfe GI
Semin Neurol; 2012 Jul; 32(3):215-26. PubMed ID: 23117946
[TBL] [Abstract][Full Text] [Related]
10. [Contribution of intravenous immunoglobulins to the treatment of myasthenia].
Gajdos P
Ann Med Interne (Paris); 2000 May; 151 Suppl 1():1S30-4. PubMed ID: 10896986
[TBL] [Abstract][Full Text] [Related]
11. [Myasthenia gravis].
Fleury MC; Tranchant C
Rev Prat; 2008 Dec; 58(20):2217-24. PubMed ID: 19209651
[TBL] [Abstract][Full Text] [Related]
12. The treatment of patients with myasthenia gravis.
Sanders DB; Scoppetta C
Neurol Clin; 1994 May; 12(2):343-68. PubMed ID: 8041346
[TBL] [Abstract][Full Text] [Related]
13. Therapy in myasthenia gravis and Lambert-Eaton myasthenic syndrome.
Newsom-Davis J
Semin Neurol; 2003 Jun; 23(2):191-8. PubMed ID: 12894384
[TBL] [Abstract][Full Text] [Related]
14. Myasthenia gravis. Pathogenesis and current concepts in management.
Havard CW; Scadding GK
Drugs; 1983 Aug; 26(2):174-84. PubMed ID: 6884241
[TBL] [Abstract][Full Text] [Related]
15. Dysphonia as a primary manifestation in myasthenia gravis (MG): a retrospective review of 7 cases among 1520 MG patients.
Liu WB; Xia Q; Men LN; Wu ZK; Huang RX
J Neurol Sci; 2007 Sep; 260(1-2):16-22. PubMed ID: 17466337
[TBL] [Abstract][Full Text] [Related]
16. [Pseudoparalytic myasthenia gravis. Diagnostic and therapeutic aspects in 60 separate cases].
Mumenthaler M; Lütschg J
Schweiz Arch Neurol Neurochir Psychiatr; 1976; 118(1):23-56. PubMed ID: 981976
[TBL] [Abstract][Full Text] [Related]
17. Laryngeal myasthenia gravis: report of 40 cases.
Mao VH; Abaza M; Spiegel JR; Mandel S; Hawkshaw M; Heuer RJ; Sataloff RT
J Voice; 2001 Mar; 15(1):122-30. PubMed ID: 12269627
[TBL] [Abstract][Full Text] [Related]
18. Myasthenia gravis: new therapeutic approaches based on pathophysiology.
Lewis RA
J Neurol Sci; 2013 Oct; 333(1-2):93-8. PubMed ID: 23938353
[TBL] [Abstract][Full Text] [Related]
19. Myasthenia gravis: clinical, immunological, and therapeutic advances.
Romi F; Gilhus NE; Aarli JA
Acta Neurol Scand; 2005 Feb; 111(2):134-41. PubMed ID: 15644074
[TBL] [Abstract][Full Text] [Related]
20. [Current therapy of myasthenia].
Zumstein V; Regli F
Rev Med Suisse Romande; 1985 Apr; 105(4):331-8. PubMed ID: 4012144
[No Abstract] [Full Text] [Related]
[Next] [New Search]
